Fang Wang

Discovery of AG-120 (Ivosidenib): A First-in-Class Mutant IDH1 Inhibitor for the Treatment of IDH1 Mutant Cancers

Janeta Popovici-Müller, René M. Lemieux, Erin Artin et al. · ACS Medicinal Chemistry Letters · 2018 · 444 citations · Full text

Medicine, Molecular Biology, Oncology +14

High tumor-infiltrating macrophage density predicts poor prognosis in patients with primary hepatocellular carcinoma after resection

Tong Ding, Jing Xu, Fang Wang et al. · Human Pathology · 2008 · 233 citations

Medicine, Oncology, Surgery +16

Initial neutrophil lymphocyte ratio is superior to platelet lymphocyte ratio as an adverse prognostic and predictive factor in metastatic colorectal cancer

Wenzhuo He, Chenxi Yin, Guifang Guo et al. · Medical Oncology · 2013 · 190 citations

Medicine, Hematology, Oncology +13

Genes associated with increased brain metastasis risk in non–small cell lung cancer: Comprehensive genomic profiling of 61 resected brain metastases versus primary non–small cell lung cancer (Guangdong Association Study of Thoracic Oncology 1036)

Hongsheng Wang, Qiuxiang Ou, Delan Li et al. · Cancer · 2019 · 134 citations · Full text

Medicine, Genetics, Oncology +17

Entinostat plus Pembrolizumab in Patients with Metastatic NSCLC Previously Treated with Anti–PD-(L)1 Therapy

Matthew D. Hellmann, Pasi A. Jänne, Mateusz Opyrchal et al. · Clinical Cancer Research · 2020 · 124 citations · Full text

Medicine, Oncology, Pharmacotherapy +17